News

Deal Announcements

Auxogyn Secures Additional Venture Capital

Thursday, June 7, 2012 5:56:00 AM PDT | VentureDeal
Menlo Park, California  --  Biotechnology company Auxogyn has garnered $18 million in new venture capital investment.

Auxogyn is developing reproductive health solutions such as its Early Embryo Viability Assessment System.




SR One led the round, which also included Kleiner Perkins Caufield & Byers, TPG Biotech and Merck Serono Ventures.
 
The company said it would use the financing to support regulatory clearance of its noninvasive assessment system.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1